Subtopic Deep Dive
GPCR Dimerization and Oligomerization
Research Guide
What is GPCR Dimerization and Oligomerization?
GPCR dimerization and oligomerization refers to the formation of homo- and heterodimers or higher-order oligomers by G protein-coupled receptors, influencing their signaling, trafficking, and pharmacology.
Studies quantify oligomer stoichiometry using FRET and BRET in native membranes. Key evidence comes from biophysical and structural analyses showing functional allostery in dimers (Angers et al., 2002; 576 citations). Over 10 papers from 1996-2021 document interfaces and pharmacological effects, with Rasmussen et al. (2011; 3001 citations) providing structural insights into β2 adrenergic receptor complexes.
Why It Matters
GPCR oligomers create novel drug targets by enabling allosteric modulation and atypical ligand pharmacology, as shown in β2-adrenergic receptor dimer disruption by transmembrane peptides (Hébert et al., 1996; 768 citations). Oligomerization explains biased signaling in opioid receptors (George et al., 2000; 551 citations) and compartmentalized cAMP signaling via PDE4 interactions (Houslay and Adams, 2003; 756 citations). These mechanisms impact cardiovascular and neurological drug design, with structures like β2-Gs complexes guiding allosteric inhibitor development (Rasmussen et al., 2011; 3001 citations).
Key Research Challenges
Quantifying Native Stoichiometry
Distinguishing physiological oligomers from artifacts in overexpression systems remains difficult. FRET/BRET data require validation in native membranes (Liang et al., 2003; 588 citations). Advanced imaging resolves stoichiometry but lacks throughput (Angers et al., 2002).
Defining Dimer Interfaces
Transmembrane domain contacts drive dimerization, but specific residues vary across GPCRs. Peptides disrupting β2 interfaces confirm functional roles (Hébert et al., 1996; 768 citations). Crystal structures reveal asymmetric interfaces in complexes (Rasmussen et al., 2011).
Linking Oligomers to Signaling
Oligomerization alters G protein coupling and desensitization, but causal mechanisms need clarification. Opioid heterodimers show unique pharmacology (George et al., 2000; 551 citations). Allosteric effects complicate ligand binding predictions.
Essential Papers
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Søren G. F. Rasmussen, Brian T. DeVree, Yaozhong Zou et al. · 2011 · Nature · 3.0K citations
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
Bertil B. Fredholm, Adriaan P. IJzerman, Kenneth A. Jacobson et al. · 2011 · Pharmacological Reviews · 1.3K citations
In the 10 years since our previous International Union of Basic and Clinical Pharmacology report on the nomenclature and classification of adenosine receptors, no developments have led to major cha...
A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation
Terence E. Hébert, Serge Moffett, Jean-Pierre Morello et al. · 1996 · Journal of Biological Chemistry · 768 citations
One of the assumptions of the mobile receptor hypothesis as it relates to G protein-coupled receptors is that the stoichiometry of receptor, G protein, and effector is 1:1:1 (Bourne, H. R., Sanders...
PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization
Miles D. Houslay, David R. Adams · 2003 · Biochemical Journal · 756 citations
cAMP is a second messenger that controls many key cellular functions. The only way to inactivate cAMP is to degrade it through the action of cAMP phosphodiesterases (PDEs). PDEs are thus poised to ...
Pharmacology of Adenosine Receptors: The State of the Art
Pier Andrea Borea, Stefania Gessi, Stefania Merighi et al. · 2018 · Physiological Reviews · 714 citations
Adenosine is a ubiquitous endogenous autacoid whose effects are triggered through the enrollment of four G protein-coupled receptors: A 1 , A 2A , A 2B , and A 3 . Due to the rapid generation of ad...
G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska et al. · 2021 · Signal Transduction and Targeted Therapy · 589 citations
Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes
Yan Liang, Dimitrios Fotiadis, Sławomir Filipek et al. · 2003 · Journal of Biological Chemistry · 588 citations
Reading Guide
Foundational Papers
Start with Hébert et al. (1996; 768 citations) for early evidence of functional β2 dimerization via peptides, then Angers et al. (2002; 576 citations) for comprehensive review, and Rasmussen et al. (2011; 3001 citations) for structural validation.
Recent Advances
Study Yang et al. (2021; 589 citations) for drug discovery in oligomers and Borea et al. (2018; 714 citations) for adenosine receptor pharmacology implications.
Core Methods
Core techniques: FRET/BRET for dynamics (George et al., 2000), crystallography for interfaces (Rasmussen et al., 2011), peptides/AFM for native organization (Hébert et al., 1996; Liang et al., 2003).
How PapersFlow Helps You Research GPCR Dimerization and Oligomerization
Discover & Search
Research Agent uses citationGraph on Rasmussen et al. (2011) to map structural studies linking β2-Gs complexes to dimer interfaces, then findSimilarPapers uncovers oligomer-focused works like Hébert et al. (1996). exaSearch queries 'GPCR homo/heterodimer FRET stoichiometry native membranes' for 250M+ OpenAlex papers, surfacing Liang et al. (2003) on rhodopsin organization.
Analyze & Verify
Analysis Agent applies readPaperContent to extract FRET/BRET data from Angers et al. (2002), then verifyResponse with CoVe cross-checks stoichiometry claims against George et al. (2000). runPythonAnalysis processes citation networks or BRET efficiency curves with NumPy/pandas for statistical verification; GRADE scores evidence strength for physiological relevance.
Synthesize & Write
Synthesis Agent detects gaps in heterodimer pharmacology via contradiction flagging across Hébert (1996) and George (2000), generating exportMermaid diagrams of dimer interfaces. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing 10+ papers, with latexCompile producing camera-ready manuscripts and gap detection highlighting unmet needs in allostery.
Use Cases
"Analyze BRET data from GPCR oligomer papers to quantify β2-adrenergic dimer stoichiometry."
Research Agent → searchPapers('β2 dimer BRET') → Analysis Agent → readPaperContent(Hébert 1996) → runPythonAnalysis(pandas curve fitting on extracted efficiencies) → matplotlib plot of stoichiometry distributions.
"Write a review on GPCR heterodimer drug targets with figures."
Synthesis Agent → gap detection(Angers 2002 + George 2000) → Writing Agent → latexGenerateFigure(dimer interfaces) → latexSyncCitations(10 papers) → latexCompile → PDF with embedded oligomer schematics.
"Find code for simulating GPCR dimer FRET efficiencies."
Research Agent → paperExtractUrls(Liang 2003) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(imported simulation code with custom parameters).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ GPCR papers: searchPapers → citationGraph(Rasmussen 2011 hub) → structured report on oligomer evolution. DeepScan applies 7-step analysis with CoVe checkpoints to verify dimer interface claims from Hébert (1996). Theorizer generates hypotheses on allosteric chaperoning from synthesis of Angers (2002) and Houslay (2003) signaling data.
Frequently Asked Questions
What defines GPCR dimerization?
GPCR dimerization is the specific association of two receptor protomers via transmembrane interfaces, forming homo- or heterodimers that alter signaling (Angers et al., 2002).
What methods quantify oligomers?
FRET and BRET measure proximity in live cells, while AFM and crystallography visualize native organization (Liang et al., 2003; Rasmussen et al., 2011).
What are key papers?
Rasmussen et al. (2011; 3001 citations) structures β2-Gs; Hébert et al. (1996; 768 citations) shows dimer inhibition; Angers et al. (2002; 576 citations) reviews ontogeny.
What open problems exist?
Challenges include proving oligomer necessity in native signaling and designing interface-specific drugs beyond peptides (George et al., 2000; Hunyady and Catt, 2005).
Research Receptor Mechanisms and Signaling with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching GPCR Dimerization and Oligomerization with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the Receptor Mechanisms and Signaling Research Guide